Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...

AI-powered medical devices are improving diagnosis and helping doctors detect diseases earlier with greater accuracy.Wearables and remote m ...

Researchers developed a scalable framework that predicts insulin resistance using wearable-device signals, routine blood biomarkers, and demographic data, with stronger performance when these data ...

Adults with prediabetes by their early 30s who had high fasting glucose levels, in addition to other risk factors such as obesity, high cholesterol or high blood pressure, had the highest risk of ...

Around 20–40% of the general population are estimated to have insulin resistance—a condition where insulin begins to be less ...

A new needle-free blood test, TAP, launched by UHMBT NHS Trust, transforms care for patients with learning disabilities or needle phobia ...

Endogenex today announced new findings supporting its technology for improving outcomes in individuals with type 2 diabetes.

Diabetes technology innovators gathered last week for the Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026).

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced the publication of 48-week results from its REGENT-1 Australia ...

A US study has shown that people with type 1 diabetes are more likely to develop dementia than the general population, highlighting the importance of following up on brain health as we age.

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...